Options
Risk and Outcomes of Complications During and After MitraClip Implantation: Experience in 828 Patients From the German TRAnscatheter Mitral Valve Interventions (TRAMI) Registry
ISSN
1522-726X
1522-1946
Date Issued
2015
Author(s)
Eggebrecht, Holger
Schelle, Sibylle
Plicht, Bjoern
von Bardeleben, Ralph Stephan
Butter, Christian
May, Andreas E.
Lubos, Edith
Boekstegers, Peter
Ouarrak, Taoufik
Senges, Jochen
Schmermund, Axel
DOI
10.1002/ccd.25838
Abstract
Aims: To analyze risk and outcomes of complications during and after MitraClip implantation using multicenter data from the prospective German Transcatheter Mitral Valve Interventions (TRAMI) registry. Methods and Results: Data of 828 patients (mean age: 76.0 [71-81] years, 327 (40%) females) undergoing MitraClip implantation in Germany between 2010 and 2013 were analyzed. Most patients (85%) underwent elective procedures with on average implantation of 1.4 +/- 0.6 clips. Emergent cardiac surgery was not required; a single patient died intraoperatively. During the in- hospital period, complications occurred in 215 (25.9%) patients, of which 106 (12.8%) were considered major. Major bleeding complications were among the most frequent major complications (7.4%), while rates of pericardial tamponade (1.9%) and clip-specific complications (embolization: 0%, partial clip detachment: 1.9%) were low. In-hospital death, stroke or myocardial infarction (MACCE) occurred in 2.2, 0.9, and 0% patients, respectively. Patients with complications appeared to be older and more critically ill pre-interventionally; in- hospital mortality was significantly higher as compared to those without procedural complications. Conclusions: MitraClip implantation appears to be a safe treatment option with low rates of MACCE and clip-specific complications.